Vasudev Jaiprakash Bailey
CIK: 0002094741
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RANI
Rani Therapeutics Holdings, Inc.
Director
Discretionary Trading P&L
Holdings
About Bailey Vasudev Jaiprakash
Bailey Vasudev Jaiprakash (SEC CIK 0002094741) files insider reports with the SEC as Director of Rani Therapeutics Holdings, Inc. (RANI).
Signal8 holds 3 ownership filings by Bailey Vasudev Jaiprakash (1 Form 3, 2 Form 4), filed between Oct 30, 2025 and Jun 1, 2026. Those filings report 2 transactions, from Oct 23, 2025 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bailey Vasudev Jaiprakash's filings is in SAN JOSE, CA.
Recent filings by Bailey Vasudev Jaiprakash
Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)
- Imran Talat, Chief Executive Officer
- Javadi Alireza, Chief Technical Officer
- Gilson Michelle, Director
- IMRAN MIR A, Director
- Maestas Nicholas, Chief Financial Officer
- McKinley Kate, Chief Business Officer